Quanterix: Why Pursuing A Big Deal For Akoya?

Stock Information for Akoya BioSciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Akoya BioSciences Inc.

Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya
$HAREHOLDER ALERT: The M&A Class Action Firm Encourages Stockholders of FNA, BECN, QTRX, PLYA to Act Now
$TOCKHOLDER ALERT: The M&A Class Action Firm Urges Shareholders of FNA, BECN, QTRX, PLYA to Take Action
Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN
Quanterix Releases Financial Results for the Fourth Quarter of 2024
Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.